(Q34723447)

4 August 2017

1 reference

title

Evidence review: efficacy and effectiveness of antidepressant treatment in primary care (English)

1 reference

4 August 2017

Gregory E Simon

1

1 reference

4 August 2017

language of work or name

1 reference

1 July 2002

1 reference

General Hospital Psychiatry

4 August 2017

published in

1 reference

4 August 2017

volume

24

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

213-224

1 reference

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Psychiatric Illness in General Practice: A Detailed Study Using a New Method of Case Identification

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Adequacy and duration of antidepressant treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A study of the use of antidepressant medication in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The quality of care for depressive and anxiety disorders in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Treating major depression in primary care practice. Eight-month clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A multifaceted intervention to improve treatment of depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Does pretreatment anxiety predict response to either bupropion SR or sertraline?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A Placebo-Controlled Study of Fluoxetine Versus Imipramine in the Acute Treatment of Atypical Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Cardiovascular effects of fluoxetine in depressed patients with heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Psychotropic drugs in the management of chronic pain syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A systematic review of antidepressants in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Double-blind trial of fluoxetine: chronic daily headache and migraine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Venlafaxine for the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effectiveness of St John's wort in major depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Maintenance Phase Efficacy of Sertraline for Chronic Depression A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Relapse of depression in primary care. Rate and clinical predictors.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

A randomized trial of relapse prevention of depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Collaborative management to achieve treatment guidelines. Impact on depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Recognition, management, and outcomes of depression in primary care.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Nondetection of depression by primary care physicians reconsidered.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Who is at risk of nondetection of mental health problems in primary care?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Care for depression in HMO patients aged 65 and older

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Patterns of antidepressant use in community practice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Course of antidepressant treatment drug type, and prescriber's specialty

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Outcomes of "inadequate" antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Are there detectable differences in quality of care or outcome of depression across primary care providers?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Randomized trial of a depression management program in high utilizers of medical care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Controlled trials of CQI and academic detailing to implement a clinical practice guideline for depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Training primary-care physicians to recognize, diagnose and manage depression: does it improve patient outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Achieving guidelines for the treatment of depression in primary care: is physician education enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Does physician education on depression management improve treatment in primary care?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Improving treatment of late life depression in primary care: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The electronic medical record: its role in disseminating depression guidelines in primary care practice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The electronic medical record. A randomized trial of its impact on primary care physicians' initial management of major depression [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Effectiveness of antidepressant pharmacotherapy: the impact of medication compliance and patient education.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Cost-effectiveness of a collaborative care program for primary care patients with persistent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

The severity of major depression and choice of treatment in primary care practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-8343%2802%2900198-6

7 January 2021

Drugs versus placebo for dysthymia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001130

Identifiers

DOI

10.1016/S0163-8343(02)00198-6

1 reference

4 August 2017

1 reference